简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-06-26 09:35 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1
2023-06-26 09:16 IPS Strengthens Asia and Pacific Presence with New Managing Director, Matthew Shippey
2023-06-26 09:08 Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
2023-06-26 08:36 Brainlab and the AO Foundation Collaborate on the Future of Immersive Medical Education and Training
2023-06-25 13:44 Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
2023-06-25 08:49 Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
2023-06-25 08:47 Children’s Hospital Los Angeles: The Best Pediatric Care in California and the Pacific Region of the United States
2023-06-25 08:18 UVDI to Introduce the New UVDI-GO™ UV LED Surface Sanitizer at APIC 2023
2023-06-25 07:59 Ferrer Initiates its ADOREXT Extension Study in Amyotrophic Lateral Sclerosis (ALS)
2023-06-16 16:27 Ferring Pharmaceuticals successfully increases its second Swiss Franc Bond offering by CHF 80 million
2023-06-16 06:47 SciMed (Asia), Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation, Becomes Wholly Owned Subsidiary -- Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific --
2023-06-15 17:41 Baby Health Care Recognized as One of the Top 10 Fetal and Neonatal Care Companies of 2023 by MEDTECH OUTLOOK
2023-06-15 14:23 First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
2023-06-14 19:10 Sound Vaccine Secures KRW 180,000,000,000 Capital Commitment from GEM as Company Seeks to Get Uplisted on KOSDAQ
2023-06-14 09:28 CORRECTING and REPLACING Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03 (Perfluorohexyloctane Ophthalmic Solution) For the Treatment of Dry Eye Disease in Japan CORRECTION...by Novaliq GmbH
2023-06-13 16:17 Community Health System Expands Use of Multiple Masimo Technologies, System-wide
2023-06-13 14:43 Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions
2023-06-12 06:56 Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
2023-06-09 18:25 Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the Signs and Symptoms of Dry Eye Disease
2023-06-09 15:55 Parse Biosciences Launches CRISPR Detect

Business Wire Weibo

Press Releases

Latest Releases